FDA Warning Letter — Namita A. Goyal, M.D.
The FDA took a Warning Letter action against Namita A. Goyal, M.D. on Oct 10, 2024 (Orange, CA). The action was issued by CBER and concerns biologics products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Namita A. Goyal, M.D.
- Date
- Oct 10, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Center
- CBER
- Location
- Orange, CA (United States)